 - Patients must have a pathologically confirmed recurrence reappearance of previously cleared squamous cell cancer in the upper aerodigestive tract or a second squamous cell primary. Patients may have experienced more than one recurrence as long as the first recurrence occurred 6 months following the end of the prior RT. 